Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 05 May | 888.70 |
10.15 (1.16%) |
OPEN
885.00 |
HIGH
899.00 |
LOW
869.55 |
| NSE 00:00 | 05 May | 888.65 |
10.20 (1.16%) |
OPEN
885.00 |
HIGH
899.00 |
LOW
869.00 |
| OPEN | 885.00 |
| PREVIOUS CLOSE | 878.55 |
| VOLUME | 657014 |
| 52-Week high | 966.00 |
| 52-Week low | 565.90 |
| P/E | 26.95 |
| Mkt Cap.(Rs cr) | 71,669 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 683.30 | 5.94 | 163944.16 | 8836.78 | 1918.11 | 12.37 | 55.24 |
| Divi's Lab. | 4035.25 | 1.20 | 107115.71 | 1701.44 | 470.62 | 70.01 | 57.64 |
| Dr Reddy's Labs | 5160.60 | 1.84 | 85820.78 | 4941.90 | 27.90 | 142.98 | 36.09 |
| Cipla | 888.70 | 1.16 | 71669.21 | 5168.69 | 752.51 | 32.98 | 26.95 |
| Cadila Health. | 601.55 | 5.66 | 61580.68 | 3795.60 | 512.50 | 17.62 | 34.14 |
| Aurobindo Pharma | 1018.10 | 6.45 | 59650.48 | 6364.91 | 2946.32 | 50.89 | 20.01 |
| Lupin | 1200.50 | 13.55 | 54472.69 | 4017.36 | 441.35 | 25.73 | 46.66 |
| Biocon | 381.30 | 2.09 | 45778.88 | 1838.70 | 296.40 | 2.34 | 162.95 |
| Torrent Pharma. | 2623.50 | 4.68 | 44394.87 | 1995.00 | 297.00 | 60.69 | 43.23 |
| Gland Pharma | 2608.95 | -1.55 | 42682.42 | 859.42 | 204.11 | 56.93 | 45.83 |
| Piramal Enterp. | 1721.10 | 3.39 | 38819.41 | 3168.61 | 799.39 | 0.00 | - |
| Alkem Lab | 2900.10 | 3.71 | 34670.70 | 2318.05 | 463.85 | 133.28 | 21.76 |
| Abbott India | 15395.70 | 0.63 | 32715.86 | 1095.37 | 177.14 | 305.50 | 50.40 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
